BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 33137202)

  • 21. COVID-19-associated venous thromboembolism portends worse survival.
    Meena RA; Sharifpour M; Gaddh M; Cui X; Xie Y; Di M; Brewster LP; Duwayri Y; Alabi O
    Semin Vasc Surg; 2021 Sep; 34(3):117-124. PubMed ID: 34642031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism in critically ill patients affected by ARDS related to COVID-19 in Northern-West Italy.
    Longhitano Y; Racca F; Zanza C; Piccioni A; Audo A; Muncinelli M; Santi R; Kozel D; Geraci C; Taverna M; Bonato V; Cassini F; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9154-9160. PubMed ID: 32965007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis.
    Porfidia A; Valeriani E; Pola R; Porreca E; Rutjes AWS; Di Nisio M
    Thromb Res; 2020 Dec; 196():67-74. PubMed ID: 32853978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.
    Lodigiani C; Iapichino G; Carenzo L; Cecconi M; Ferrazzi P; Sebastian T; Kucher N; Studt JD; Sacco C; Bertuzzi A; Sandri MT; Barco S;
    Thromb Res; 2020 Jul; 191():9-14. PubMed ID: 32353746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
    Fontana P; Casini A; Robert-Ebadi H; Glauser F; Righini M; Blondon M
    Swiss Med Wkly; 2020 Jun; 150():w20301. PubMed ID: 32640479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
    Gulati S; Hsu CY; Shah S; Shah PK; Zon R; Alsamarai S; Awosika J; El-Bakouny Z; Bashir B; Beeghly A; Berg S; de-la-Rosa-Martinez D; Doroshow DB; Egan PC; Fein J; Flora DB; Friese CR; Fromowitz A; Griffiths EA; Hwang C; Jani C; Joshi M; Khan H; Klein EJ; Heater NK; Koshkin VS; Kwon DH; Labaki C; Latif T; McKay RR; Nagaraj G; Nakasone ES; Nonato T; Polimera HV; Puc M; Razavi P; Ruiz-Garcia E; Saliby RM; Shastri A; Singh SRK; Tagalakis V; Vilar-Compte D; Weissmann LB; Wilkins CR; Wise-Draper TM; Wotman MT; Yoon JJ; Mishra S; Grivas P; Shyr Y; Warner JL; Connors JM; Shah DP; Rosovsky RP;
    JAMA Oncol; 2023 Oct; 9(10):1390-1400. PubMed ID: 37589970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
    Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
    Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of chemical thromboprophylaxis in critically ill medical and surgical patients with sepsis.
    Hanify JM; Dupree LH; Johnson DW; Ferreira JA
    J Crit Care; 2017 Feb; 37():206-210. PubMed ID: 27969572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The management of venous thromboembolism in hospitalized patients with COVID-19.
    Spyropoulos AC
    Blood Adv; 2020 Aug; 4(16):4028. PubMed ID: 32841342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients.
    Cohen SL; Gianos E; Barish MA; Chatterjee S; Kohn N; Lesser M; Giannis D; Coppa K; Hirsch JS; McGinn TG; Goldin ME; Spyropoulos AC;
    Thromb Haemost; 2021 Aug; 121(8):1043-1053. PubMed ID: 33472255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy.
    Melazzini F; Colaneri M; Fumoso F; Freddi G; Lenti MV; Pieri TC; Piloni D; Noris P; Pieresca C; Preti PS; Russo M; Corsico A; Tavazzi G; Baldanti F; Triarico A; Mojoli F; Bruno R; Di Sabatino A;
    Intern Emerg Med; 2021 Aug; 16(5):1141-1152. PubMed ID: 33161478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19.
    Fernández-Capitán C; Barba R; Díaz-Pedroche MDC; Sigüenza P; Demelo-Rodriguez P; Siniscalchi C; Pedrajas JM; Farfán-Sedano AI; Olivera PE; Gómez-Cuervo C; Llamas P; Villares P; Sanchez O; López-Reyes R; Catella J; Bikdeli B; Weinberg I; Tafur AJ; Jiménez D; Monreal M
    Semin Thromb Hemost; 2021 Jun; 47(4):351-361. PubMed ID: 33086403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
    Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
    Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.
    Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC
    Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    Thromb Res; 2020 Dec; 196():313-317. PubMed ID: 32977129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Children and young adults hospitalized for severe COVID-19 exhibit thrombotic coagulopathy.
    Mitchell WB; Davila J; Keenan J; Jackson J; Tal A; Morrone KA; Silver EJ; O'Brien S; Manwani D
    Pediatr Blood Cancer; 2021 Jul; 68(7):e28975. PubMed ID: 33661561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward.
    Avruscio G; Camporese G; Campello E; Bernardi E; Persona P; Passarella C; Noventa F; Cola M; Navalesi P; Cattelan A; Tiberio I; Boscolo A; Spiezia L; Simioni P;
    Clin Transl Sci; 2020 Nov; 13(6):1108-1114. PubMed ID: 32989908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19.
    Giannis D; Barish MA; Goldin M; Cohen SL; Kohn N; Gianos E; Chatterjee S; Lesser M; Coppa K; Hirsch JS; McGinn T; Spyropoulos AC;
    J Thromb Thrombolysis; 2021 May; 51(4):897-901. PubMed ID: 33665766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence of venous thromboembolism in critically ill patients with COVID-19 compared with critically ill non-COVID patients.
    Boyd S; Martin-Loeches I
    Ir J Med Sci; 2021 Nov; 190(4):1317-1320. PubMed ID: 33415688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.